Follow the people · Insider
Lynn Sebastian Purcell
Lynn Sebastian Purcell files insider transactions with the SEC as a director and 10% owner of Conexeu Sciences. We hold 2 disclosed purchases and sales filed since 14 May 2026, 1 of them in the last 90 days.
- Files for 2 companiesCNXU, CXNU
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure9 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 18 June 2026 — 4 September 2026Director and 10% owner · Conexeu Sciences 7 Form 4 lines · source: SEC Form 4
- Filed 12 May 2026 — 12 May 2026Director and 10% owner · Conexeu Sciences 3 Form 4 lines · source: SEC Form 4
Every transaction
10 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 4 Sep 2026 | 9 Sep 2026SEC Form 4 | 5 d | exercised in-the-money optionsnot a trade | Conexeu Sciences | 217,608 shares | down −10.3% | up +0.0% |
| 4 Sep 2026 | 9 Sep 2026SEC Form 4 | 5 d | exercised in-the-money optionsnot a trade | Conexeu Sciencesderivative | 217,608 shares | down −10.3% | up +0.0% |
| 4 Sep 2026 | 9 Sep 2026SEC Form 4 | 5 d | exercised in-the-money optionsnot a trade | Conexeu Sciences | 217,608 shares | down −10.3% | up +0.0% |
| 4 Sep 2026 | 9 Sep 2026SEC Form 4 | 5 d | exercised in-the-money optionsnot a trade | Conexeu Sciencesderivative | 217,608 shares | down −10.3% | up +0.0% |
| 18 Jun 2026 | 23 Jun 2026SEC Form 4 | 5 d | bought on the open market | Conexeu Sciences | 202,500 shares | down −66.4% | down −57.7% |
| 18 Jun 2026 | 23 Jun 2026SEC Form 4 | 5 d | bought on the open marketnot a trade | Conexeu Sciencesderivative | 202,500 shares | down −66.4% | down −57.7% |
| 18 Jun 2026 | 23 Jun 2026SEC Form 4 | 5 d | exercised options overnot a trade | Conexeu Sciencesderivative | 202,500 shares | down −66.4% | down −57.7% |
| 12 May 2026 | 14 May 2026SEC Form 4 | 2 d | bought on the open market | Conexeu Sciences | 422,500 shares | — | — |
| 12 May 2026 | 14 May 2026SEC Form 4 | 2 d | sold on the open marketnot a trade | Conexeu Sciencesderivative | 422,500 shares | — | — |
| 12 May 2026 | 14 May 2026SEC Form 4 | 2 d | bought on the open marketnot a trade | Conexeu Sciencesderivative | 422,500 shares | — | — |
Both percentages are the stock’s move, not Lynn Sebastian Purcell’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 9 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 7 of the 10 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.